Galena Biopharma (GALE) +7.8% premarket after saying studies of its NeuVax treatment continue to...

|About: Galena Biopharma, Inc. (GALE)|By:, SA News Editor

Galena Biopharma (GALE) +7.8% premarket after saying studies of its NeuVax treatment continue to demonstrate excellent safety and efficacy profiles.